A new validated SPE-HPLC method for monitoring crocetin in human plasma-Application after saffron tea consumption

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 3, 2011, Pages 563-568

  Chryssanthi, Dimitra G ^a   Lamari, Fotini N ^a   Georgakopoulos, Constantine D ^b   Cordopatis, Paul ^a  

^a Department of Pharmacy   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Crocetin; Crocus sativus; HPLC; Human plasma; Saffron; Solid phase extraction

Indexed keywords

AMMONIUM ACETATE; CRESOL; CROCETIN; DIMETHYL SULFOXIDE; METHANOL; PLANT EXTRACT; SAFFRON TEA EXTRACT; SODIUM DIHYDROGEN PHOSPHATE; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG; WATER;

ACCURACY; ARTICLE; CHROMATOGRAPHY; CIS ISOMER; CONTROLLED STUDY; DRUG DETERMINATION; FLOW RATE; HUMAN; HUMAN CELL; IN VIVO STUDY; ISOMERIZATION; MONITORING; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TEA; VALIDATION PROCESS; VITAMIN BLOOD LEVEL;

ADULT; BEVERAGES; CAROTENOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROCUS; DRUG MONITORING; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION;

EID: 79953220423     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.02.018     Document Type: Article

References (21)

1. Matthew B. Crocus: A Revision of the Genus Crocus 1983, Timber Press.
2. Ferrence S.C., Bendersky G. Therapy with saffron and the goddess at Thera. Perspect. Biol. Med. 2004, 47:199-226.
3. WHO Monographs on Selected Medicinal Plants 2007, vol. 3. World Health Organization, pp. 126-135.
4. Mohajeri D., Mousavi G., Mesgari M., Doustar Y., Khayat Nouri M. Subacute toxicity of Crocus sativus L. (Saffron) stigma ethanolic extract in rats. Am. J. Pharm. Toxicol. 2007, 2:189-193.
5. Modaghegh M.H., Shahabian M., Esmaeili H.A., Rajbai O., Hosseinzadeh H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine 2008, 15:1032-1037.
6. Shamsa A., Hosseinzadeh H., Molaei M., Shakeri M.T., Rajabi O. Evaluation of Crocus sativus L. (saffron) on male erectile dysfunction: a pilot study. Phytomedicine 2009, 16:690-693.
7. Akhondzadeh S., Shafiee Sabet M., Harirchian M.H., Togha M., Cheraghmakani H., Razeghi S., Hejaz S.S., Yousefi M.H., Alimardani R., Jamshidi A., Rezazadeh S.A., Yousefi A., Zare F., Moradi A., Vossoughi A. A 22-week multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. Psychopharmacology (Berl.) 2010, 207:637-643.
8. Agha-Hosseini M., Kashani L., Aleyaseen A., Ghoreishi A., Rahmanpour H., Zarrinara A.R., Akhondzadeh S. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG 2008, 115:515-519.
9. Verma S.K., Bordia A. Antioxidant property of Saffron in man. Indian J. Med. Sci. 1998, 52:205-207.
10. Asai A., Nakano T., Takahashi M., Nagao A. Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice. J. Agric. Food Chem. 2005, 53:7302-7306.
11. Xi L., Qian Z., Du P., Fu J. Pharmacokinetic properties of crocin (crocetin digentiobiose ester) following oral administration in rats. Phytomedicine 2007, 14:633-636.
12. Guidance for Industry - Bioanalytical Method Validation 2001, U.S. Department of Health and Human Services - Food and Drug Administration (CDER).
13. Lozano P., Castellar M.R., Simancas M.J., Iborra J.L. Quantitative high-performance liquid chromatographic method to analyse commercial saffron (Crocus sativus L.) products. J. Chromatogr. A 1999, 830:477-483.
14. Tarantilis P.A., Tsoupras G., Polissiou M. Determination of saffron (Crocus sativus L.) components in crude plant extract using high-performance liquid chromatography-UV-visible photodiode-array detection-mass spectrometry. J. Chromatogr. A 1995, 699:107-118.
15. Carmona M., Zalacain A., Pardo J.E., Lopez E., Alvarruiz A., Alonso G.L. Influence of different drying and aging conditions on saffron constituents. J. Agric. Food Chem. 2005, 53:3974-3979.
16. Tarantilis P.A., Polissiou M., Manfait M. Separation of picrocrocin, cis-trans-crocins and safranal of saffron using high-performance liquid chromatography with photodiode-array detection. J. Chromatogr. A 1994, 664:55-61.
17. Kanakis C.D., Tarantilis P.A., Tajmir-Riahi H.A., Polissiou M.G. Interaction of tRNA with safranal, crocetin, and dimethylcrocetin. J. Biomol. Struct. Dyn. 2007, 24:537-546.
18. Kanakis C.D., Tarantilis P.A., Tajmir-Riahi H.A., Polissiou M.G. Crocetin dimethylcrocetin, and safranal bind human serum albumin: stability and antioxidative properties. J. Agric. Food Chem. 2007, 55:970-977.
19. Papandreou M.A., Kanakis C.D., Polissiou M.G., Efthimiopoulos S., Cordopatis P., Margarity M., Lamari F.N. Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J. Agric. Food Chem. 2006, 54:8762-8768.
20. Pfander H. Carotenoid glycosides. Pure Appl. Chem. 1976, 47:121-128.
21. Wu K., Schwartz S.J., Platz E.A., Clinton S.K., Erdman J.W., Ferruzzi M.G., Willett W.C., Giovannucci E.L. Variations in plasma lycopene and specific isomers over time in a cohort of U.S. men. J. Nutr. 2003, 133:1930-1936.